Biogen, Intercept post double-digit gains

A strong earnings report and a favorable ruling from the FDA help Biogen and Intercept to double-digit gains Friday
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.